| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
dysregulation of synaptic plasticity markers in schizophrenia. |
2023-01-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
since the regulation of synaptic plasticity has functional implications in various aspects of cognition such as learning, memory, and neural circuit maturation, the dysregulation of synaptic plasticity is considered as a pathobiological feature of schizophrenia. |
2023-01-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
the findings from our recently concluded studies indicate that there is an alteration in levels of synaptic plasticity markers such as neural cell adhesion molecule-1 (ncam-1), neurotropin-3 (nt-3) and matrix-mettaloproteinase-9 (mmp-9) in schizophrenia patients. |
2023-01-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
the objective of the present article is to review the role of markers of synaptic plasticity in schizophrenia. |
2023-01-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
pubmed database (http;//www.ncbi.nlm.nih.gov/pubmed) was used to perform an extensive literature search using the keywords schizophrenia and synaptic plasticity. |
2023-01-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesh. Dysregulation of Synaptic Plasticity Markers in Schizophrenia. Indian journal of clinical biochemistry : IJCB. vol 38. issue 1. 2023-01-23. PMID:36684500. |
we conclude that markers of synaptic plasticity are altered in schizophrenia and may lead to complications of schizophrenia including cognitive dysfunction. |
2023-01-23 |
2023-08-14 |
Not clear |
| Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua H. Synaptic plasticity in schizophrenia pathophysiology. IBRO neuroscience reports. vol 13. 2023-01-02. PMID:36590092. |
synaptic plasticity in schizophrenia pathophysiology. |
2023-01-02 |
2023-08-14 |
Not clear |
| Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua H. Synaptic plasticity in schizophrenia pathophysiology. IBRO neuroscience reports. vol 13. 2023-01-02. PMID:36590092. |
recently, the synaptopathology and the dysregulated synaptic plasticity and function have emerging as intriguing and prominent biological mechanisms of schizophrenia pathogenesis. |
2023-01-02 |
2023-08-14 |
Not clear |
| Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua H. Synaptic plasticity in schizophrenia pathophysiology. IBRO neuroscience reports. vol 13. 2023-01-02. PMID:36590092. |
synaptic plasticity is the ability of neurons to change the strength of their connections in response to internal or external stimuli, which is essential for brain development and function, learning and memory, and vast majority of behavior responses relevant to psychiatric diseases including schizophrenia. |
2023-01-02 |
2023-08-14 |
Not clear |
| Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua H. Synaptic plasticity in schizophrenia pathophysiology. IBRO neuroscience reports. vol 13. 2023-01-02. PMID:36590092. |
recent genome-wide association studies have provided fruitful findings of hundreds of risk gene variances associated with schizophrenia, thus further clarifying the role of these disease-risk genes in synaptic transmission and plasticity will be beneficial to advance our understanding of schizophrenia pathology, as well as the molecular mechanism of synaptic plasticity. |
2023-01-02 |
2023-08-14 |
Not clear |
| Andrea de Bartolomeis, Giuseppe De Simone, Mariateresa Ciccarelli, Alessia Castiello, Benedetta Mazza, Licia Vellucci, Annarita Baron. Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance. Biomedicines. vol 10. issue 12. 2022-12-23. PMID:36551939. |
schizophrenia is a severe mental illness characterized by alterations in processes that regulate both synaptic plasticity and functional connectivity between brain regions. |
2022-12-23 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesha, Medha Rajappa, Vikas Meno. Relationship Between Neural Cell Adhesion Molecule-1 and Cognitive Functioning in Schizophrenia Spectrum Disorder. Indian journal of clinical biochemistry : IJCB. vol 37. issue 4. 2022-10-20. PMID:36262784. |
abnormal synaptic plasticity leads to cognitive impairment in schizophrenia. |
2022-10-20 |
2023-08-14 |
Not clear |
| Neha Keshri, Hanumanthappa Nandeesha, Medha Rajappa, Vikas Meno. Relationship Between Neural Cell Adhesion Molecule-1 and Cognitive Functioning in Schizophrenia Spectrum Disorder. Indian journal of clinical biochemistry : IJCB. vol 37. issue 4. 2022-10-20. PMID:36262784. |
markers of synaptic plasticity are known to be altered in schizophrenia, but there are limited data available about neural cell adhesion molecule-1 (ncam-1) levels and its association with cognitive functions in schizophrenia. |
2022-10-20 |
2023-08-14 |
Not clear |
| Ashley J McFalls, G Imperio Ceasar, Emma Woodward, Claire Krikorian, Stoltsfus Brooke, Benjamin Wronowski, Patricia S Grigson, Willard M Freeman, Kent E Vran. An RNA-seq Study of the mPFC of rats with Different Addiction Phenotypes. Brain research bulletin. 2022-10-12. PMID:36223840. |
genes found to be differentially expressed were those associated with schizophrenia and dopamine signaling, signal transduction, development and synaptic plasticity. |
2022-10-12 |
2023-08-14 |
rat |
| Xiu-Lin Wu, Qiu-Jin Yan, Fan Zh. Abnormal synaptic plasticity and impaired cognition in schizophrenia. World journal of psychiatry. vol 12. issue 4. 2022-05-18. PMID:35582335. |
abnormal synaptic plasticity and impaired cognition in schizophrenia. |
2022-05-18 |
2023-08-13 |
Not clear |
| Yu-Yuan Wang, Shih-Hsin Hsu, Hsin-Yao Tsai, Fu-Yu Cheng, Min-Chih Chen. Transcriptomic and Proteomic Analysis of CRISPR/Cas9-Mediated International journal of molecular sciences. vol 23. issue 9. 2022-05-14. PMID:35562887. |
transcriptomic and proteomic analysis of crispr/cas9-mediated arc/arg3.1 (activity-regulated cytoskeletal-associated protein (arc)) is a critical regulator of long-term synaptic plasticity and is involved in the pathophysiology of schizophrenia. |
2022-05-14 |
2023-08-13 |
human |
| Shalini Dogra, P Jeffrey Con. Activation of group II metabotropic glutamate (mGlu2/3) receptors regulates excitatory synaptic plasticity in the nucleus accumbens: Implications for the treatment of schizophrenia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35554561. |
activation of group ii metabotropic glutamate (mglu2/3) receptors regulates excitatory synaptic plasticity in the nucleus accumbens: implications for the treatment of schizophrenia. |
2022-05-13 |
2023-08-13 |
Not clear |
| Mohammad M Khan, Vinay Parik. Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors. CNS & neurological disorders drug targets. 2022-04-03. PMID:35366786. |
since neurotrophic factors are the primary architects of neurogenesis, synaptic plasticity, learning and memory, the findings from preclinical and clinical studies that assess changes in neurogenesis and neurotrophic factors and their relationship to cognitive performance in schizophrenia, and how these mechanisms might be impacted by apd treatment, may provide valuable clues in developing therapies to combat cognitive deficit in schizophrenia. |
2022-04-03 |
2023-08-13 |
Not clear |
| Haidong Yang, Wen Pan, Wenhuan Xiao, Man Yang, Jianchun Xu, Jin Li, Xiaobin Zhan. Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms. BMC psychiatry. vol 22. issue 1. 2022-03-26. PMID:35337293. |
neuregulin1 (nrg1) plays a role in neuronal migration, regulation of synaptic plasticity, and neural survival, and has been considered to be among the candidate genes for schizophrenia. |
2022-03-26 |
2023-08-13 |
Not clear |
| Arianna De Rosa, Andrea Fontana, Tommaso Nuzzo, Martina Garofalo, Anna Di Maio, Daniela Punzo, Massimiliano Copetti, Alessandro Bertolino, Francesco Errico, Antonio Rampino, Andrea de Bartolomeis, Alessandro Usiell. Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain. NPJ schizophrenia. vol 8. issue 1. 2022-02-26. PMID:35217646. |
schizophrenia is a disorder of synaptic plasticity and aberrant connectivity in which a major dysfunction in glutamate synapse has been suggested. |
2022-02-26 |
2023-08-13 |
Not clear |